Figure a–b depictsa prominent decrease in tumor volume in treated groups compared tocontrol and Quercetin­(25 mg/kg) groups. Immunofluorescence imagesin Figure c–ddemonstrated reduced NOX4, VEGF, and Ki-67 expression, accompanied by alterations in EMT markers (N-Cadherin,E-Cadherin, Vimentin), indicating a multipronged antitumor response. The gene discussed is CDH1; the disease is neoplasm.